Recent Updates
Recently added Catalysts
INO Positive Sentiment Score: 70/100

INOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024

Wednesday, February 21, 2024 1 min read
Key Takeaway: INOVIO has announced the release date for its fourth quarter and year-end 2023 financial results, which will occur after the market closes on March 6, 2024. Following the announcement, the company will conduct a live conference call and webcast at 4:30 p.m. ET. This event aims to discuss the financial outcomes and offer a general business update while allowing for a Q&A session with analysts. INOVIO specializes in DNA medicines aimed at addressing HPV-related diseases, cancer, and infectious diseases.

Market Sentiment Analysis

POSITIVE FACTORS

  • INOVIO is set to provide an update on its financial results, indicating active corporate engagement.
  • The hosting of a live Q&A suggests transparency and willingness to engage with analysts and stakeholders.
  • Focus on developing innovative DNA medicines could indicate potential future growth and advancements.

Full Press Release Details

PLYMOUTH MEETING, Pa., Feb. 21, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases, today announced that fourth quarter and year-end 2023 financial results will be released after the market close on March 6, 2024. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update.
The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.
Media: Jennie Willson (267) 429-8567 [email protected]
Investors: Thomas Hong (267) 440-4298 [email protected]
SOURCE INOVIO Pharmaceuticals, Inc.

21 %

more press release views with

Frequently Asked Questions

When will INOVIO release its 2023 financial results?

INOVIO will announce its 2023 financial results after the market closes on March 6, 2024.

How can I access the live conference call by INOVIO?

The live conference call can be accessed online at INOVIO's investor relations website.

Will there be a Q&A session during the INOVIO webinar?

Yes, the live webcast will include a Q&A session with analysts.

How long will the INOVIO webcast be available for replay?

The webcast will be available for replay for 90 days after the event.

What diseases does INOVIO focus on in its research?

INOVIO focuses on HPV-related diseases, cancer, and infectious diseases through DNA medicines.

Tags: INO Viatris Investor Conferences Healthcare INOVIO HPV DNA medicines 2023 financial results biotechnology
Last updated: Feb 21, 2024